150 related articles for article (PubMed ID: 24852247)
1. Measuring HIV-related mortality in the first decade of anti-retroviral therapy in sub-Saharan Africa.
Todd J; Slaymaker E; Zaba B; Mahy M; Byass P
Glob Health Action; 2014; 7():24787. PubMed ID: 24852247
[No Abstract] [Full Text] [Related]
2. Sex Differences in Mortality and Loss Among 21,461 Older Adults on Antiretroviral Therapy in Sub-Saharan Africa.
Agarwal M; Lamb MR; Howard AA; Abrams E; El-Sadr WM; Elul B
J Acquir Immune Defic Syndr; 2016 Oct; 73(2):e33-5. PubMed ID: 27632148
[No Abstract] [Full Text] [Related]
3. Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review.
Adejumo OA; Malee KM; Ryscavage P; Hunter SJ; Taiwo BO
J Int AIDS Soc; 2015; 18(1):20049. PubMed ID: 26385853
[TBL] [Abstract][Full Text] [Related]
4. HIV agenda must be prioritised to reduce deaths from AIDS in sub-Saharan Africa.
Cousins S
BMJ; 2017 Jul; 358():j3638. PubMed ID: 28751474
[No Abstract] [Full Text] [Related]
5. Antiretroviral therapy in sub-Saharan Africa.
Müller O; Corrah T; Katabira E; Plummer F; Mabey D
Lancet; 1998 Jan; 351(9095):68. PubMed ID: 9433449
[No Abstract] [Full Text] [Related]
6. Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.
Boender TS; Hoenderboom BM; Sigaloff KC; Hamers RL; Wellington M; Shamu T; Siwale M; Labib Maksimos EE; Nankya I; Kityo CM; Adeyemo TA; Akanmu AS; Mandaliya K; Botes ME; Ondoa P; Rinke de Wit TF
Clin Infect Dis; 2015 Dec; 61(11):1749-58. PubMed ID: 26240203
[TBL] [Abstract][Full Text] [Related]
7. Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.
Verguet S; Lim SS; Murray CJ; Gakidou E; Salomon JA
J Infect Dis; 2013 Jan; 207(1):72-9. PubMed ID: 23100567
[TBL] [Abstract][Full Text] [Related]
8. Eliminating preventable HIV-related maternal mortality in sub-Saharan Africa: what do we need to know?
Kendall T; Danel I; Cooper D; Dilmitis S; Kaida A; Kourtis AP; Langer A; Lapidos-Salaiz I; Lathrop E; Moran AC; Sebitloane H; Turan JM; Watts DH; Wegner MN
J Acquir Immune Defic Syndr; 2014 Dec; 67 Suppl 4(Suppl 4):S250-8. PubMed ID: 25436825
[TBL] [Abstract][Full Text] [Related]
9. HIV and maternal mortality.
Lathrop E; Jamieson DJ; Danel I
Int J Gynaecol Obstet; 2014 Nov; 127(2):213-5. PubMed ID: 25097142
[TBL] [Abstract][Full Text] [Related]
10. Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival.
Staehelin C; Rickenbach M; Low N; Egger M; Ledergerber B; Hirschel B; D'Acremont V; Battegay M; Wagels T; Bernasconi E; Kopp C; Furrer H;
AIDS; 2003 Oct; 17(15):2237-44. PubMed ID: 14523281
[TBL] [Abstract][Full Text] [Related]
11. Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy.
Nagu TJ; Aboud S; Mwiru R; Matee MI; Rao M; Fawzi WW; Zumla A; Maeurer MJ; Mugusi F
Int J Infect Dis; 2017 Mar; 56():39-44. PubMed ID: 28161460
[TBL] [Abstract][Full Text] [Related]
12. Sub-Saharan Africa: two reports criticize strategies. Epidemic problems show progress and problems.
AIDS Alert; 2006 Jul; 21(7):suppl 4. PubMed ID: 16871673
[No Abstract] [Full Text] [Related]
13. Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis.
Siedner MJ; Ng CK; Bassett IV; Katz IT; Bangsberg DR; Tsai AC
Clin Infect Dis; 2015 Apr; 60(7):1120-7. PubMed ID: 25516189
[TBL] [Abstract][Full Text] [Related]
14. Delivery of antiretroviral therapy in sub-saharan Africa.
Weller I
Clin Infect Dis; 2006 Sep; 43(6):777-8. PubMed ID: 16912955
[No Abstract] [Full Text] [Related]
15. Does early ART in sub-Saharan Africa decrease mortality?
Katz IT; Siedner MJ
Lancet HIV; 2015 Sep; 2(9):e354-5. PubMed ID: 26423540
[No Abstract] [Full Text] [Related]
16. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa.
Sutcliffe CG; van Dijk JH; Bolton C; Persaud D; Moss WJ
Lancet Infect Dis; 2008 Aug; 8(8):477-89. PubMed ID: 18652994
[TBL] [Abstract][Full Text] [Related]
17. Mortality after failure of antiretroviral therapy in sub-Saharan Africa.
Keiser O; Tweya H; Braitstein P; Dabis F; MacPhail P; Boulle A; Nash D; Wood R; Lüthi R; Brinkhof MW; Schechter M; Egger M;
Trop Med Int Health; 2010 Feb; 15(2):251-8. PubMed ID: 20003034
[TBL] [Abstract][Full Text] [Related]
18. Mortality along the continuum of HIV care in Rwanda: a model-based analysis.
Bendavid E; Stauffer D; Remera E; Nsanzimana S; Kanters S; Mills EJ
BMC Infect Dis; 2016 Dec; 16(1):728. PubMed ID: 27905895
[TBL] [Abstract][Full Text] [Related]
19. Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America.
Zhou J; Jaquet A; Bissagnene E; Musick B; Wools-Kaloustian K; Maxwell N; Boulle A; Wehbe F; Masys D; Iriondo-Perez J; Hemingway-Foday J; Law M;
J Int AIDS Soc; 2012 Jan; 15(1):5. PubMed ID: 22289654
[TBL] [Abstract][Full Text] [Related]
20. Pediatric Access and Continuity of HIV Care Before the Start of Antiretroviral Therapy in Sub-Saharan Africa.
Bastard M; Poulet E; Nicolay N; Szumilin E; Balkan S; Pujades-Rodriguez M
Pediatr Infect Dis J; 2016 Sep; 35(9):981-6. PubMed ID: 27187757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
